In-depth interviews conducted by researchers at the Johns Hopkins University School of Medicine of 20 young women attending an urban sexually transmitted disease clinic have documented a variety of… …read more
The fertility cycle in mammalian females becomes more irregular during the transition to menopause. …read more
Dr Andrew Kaunitz summarizes the issues you need to be aware of before prescribing flibanserin (Addyi). Medscape Ob/Gyn …read more
Currently, most cases of ductal carcinoma in situ (DCIS) are treated with the standard of lumpectomy plus radiotherapy. But is it all necessary with such a very low death rate at 20 years? Medscape Medical News …read more
Scientists identify PCOS susceptibility that appears to be unique to European womenPolycystic ovary syndrome (PCOS) has been passed down in many families for generations — causing reproductive… …read more
The combination of doxylamine and vitamin B6 is back on the market and recommended as a first-line therapy. The authors also review the latest research on ondansetron. Medscape Medical News …read more
New emergency contraception guidelines from the American College of Obstetricians and Gynecologists include an expanded discussion and guidance on the use of ulipristal acetate. Medscape Medical News …read more
Commercial screening tests that purport to predict early-onset preeclampsia may do more harm than good and are not recommended, according to the American College of Obstetricians and… …read more
Physicians should consider early treatment of nausea and vomiting in pregnancy to prevent progression to hyperemesis gravidarum, according to an updated practice bulletin from the American College of… …read more
The FDA have approved the first ever drug to treat low sexual desire in premenopausal women. Flibanserin – brand name Addyi – will be available from mid-October. …read more